Preoperative prediction of Ki-67 expression and prognosis in breast cancer based on contrast-enhanced cone-beam breast CT: a two-centre study.
Authors
Affiliations (9)
Affiliations (9)
- Department of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, Tianjin Medical University Cancer Institute & Hospital; National Clinical Research Centre for Cancer; Tianjin's Clinical Research Centre for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education; State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Huan-Hu-Xi Road, Ti-Yuan-Bei, Hexi District, Tianjin, 300060, China.
- Department of Radiology, Qilu Hospital of Shandong University, Wen-Hua-Xi Road, Lixia District, Jinan, Shandong, 250012, China.
- Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440 Jiyan Road, Huaiyin District, Jinan, Shandong, 250117, China.
- Department of Medical Imaging, Jinan Third People's Hospital, No.1 Wangsheren North Street, Industrial North Road, Licheng District, Jinan, Shandong, 250132, China.
- Department of Medical Imaging and Image-guided Therapy, Sun Yat-Sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Dong-Feng-Dong Road, Yuexiu District, Guangzhou, Guangdong, 510060, China.
- Department of Gynecology, Qilu Hospital of Shandong University, Wen-Hua-Xi Road, Lixia District, Jinan, Shandong, 250012, China.
- Department of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, Tianjin Medical University Cancer Institute & Hospital; National Clinical Research Centre for Cancer; Tianjin's Clinical Research Centre for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education; State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Huan-Hu-Xi Road, Ti-Yuan-Bei, Hexi District, Tianjin, 300060, China. [email protected].
- Department of Medical Imaging, Radboud University Medical Centre, PO Box 9101, Nijmegen, 6500 HB, The Netherlands. [email protected].
- Department of Radiology, Medical Artificial General Intelligence for Computation (MAGIC) Lab, Tianjin Medical University Cancer Institute & Hospital; National Clinical Research Centre for Cancer; Tianjin's Clinical Research Centre for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education; State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Huan-Hu-Xi Road, Ti-Yuan-Bei, Hexi District, Tianjin, 300060, China. [email protected].
Abstract
This study aimed to develop and validate preoperative contrast-enhanced cone-beam breast CT (CE-CBBCT)-based radiomics, deep learning, and combined models for predicting Ki-67 expression status and to preliminarily explore their prognostic value, with the goal of informing preoperative treatment decisions. This two-centre study enrolled 636 breast cancer patients, divided into training (n = 310), internal validation (n = 77), external test (n = 78), and prognostic (n = 171) cohorts. Two Ki-67 cut-offs (14% and 30%) were applied. Radiomics models were constructed using five machine learning classifiers, and deep learning models using four three-dimensional architectures (ResNet50, ResNet101, DenseNet121, and ShuffleNet). The best-performing models from each category were integrated with the clinical model using logistic regression to establish combined models. Prognostic value was evaluated using disease-free survival (DFS) in the prognostic cohort. Among the radiomics models, those based on ExtraTrees and eXtreme Gradient Boosting performed best for the 14% and 30% cut-offs, respectively, with areas under the receiver operating characteristic curves (AUCs) of 0.885 and 0.831 in the external test cohort. Among the deep learning architectures, ShuffleNet performed best, with corresponding AUCs of 0.630 and 0.825. Combined models achieved the highest AUCs of 0.895 and 0.869 for the 14% and 30% cut-offs, respectively, in the external test cohort. However, they did not significantly outperform the corresponding radiomics models. In survival analysis, the radiomics score for predicting Ki-67 ≥ 30% was an independent prognostic factor for DFS (hazard ratio: 1.661; 95% confidence interval: 1.142-2.417; P = 0.008). CE-CBBCT-based radiomics models demonstrated utility as non-invasive tools for the preoperative prediction of high Ki-67 expression defined at both the 14% and 30% cut-offs. The prognostic value of the radiomics score for predicting Ki-67 ≥ 30% was preliminarily demonstrated.